- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01604434
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part III
February 18, 2019 updated by: Wally Carlo, University of Alabama at Birmingham
Randomized Evaluation of the Use of Plastic Bags to Prevent Neonatal Hypothermia in Developing Countries-Part III
The overall hypothesis is that plastic bags used in combination with WHO thermoregulation care will reduce the incidence of hypothermia in preterm/low birth weight and full term infants when compared to routine WHO thermoregulation care alone.
Part III is for preterm/low birth weight infants with or without a plastic torso wrap during the first hour after birth to assist with temperature regulation during placement in an incubator.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
Incubators in the developing world often lack humidifiers.
The resting dry heat increases evaporative heat loss, the most prominent form of heat loss in premature infants due to their increased body surface area and immature stratum corneum.
By potentially increasing humidity around the infants and decreasing evaporative heat losses, plastic bags may improve incubator warming.
This study will compare the incidence of hypothermia in infants placed in an incubator for at least one hour randomized to receive standard incubator protocol (control group) or standard incubator protocol plus a plastic bag covering their torsos and lower extremities (intervention group).
The axillary temperature of each infant will be taken before placement into the incubator and one hour later when the bag will be removed.
Blood pressure, blood sugar, seizures, weight gain, hyperthermia, death, observation for respiratory distress syndrome, bronchopulmonary dysplasia, pneumothorax, sepsis, intraventricular hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, intestinal perforation, pulmonary hemorrhage, incubator temperature, and humidity, and length of time in an incubator will be recorded throughout the hospitalization for all infants.
With an estimated baseline hypothermia rate of 90% and a hypothesized 20% absolute risk reduction (22% relative risk reduction), a sample size of 118 will be used to have a power of 80% and a confidence interval of 95%.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lusaka, Zambia
- University Teaching Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 minute to 3 days (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Infant admitted to the NICU
- Current weight between 1,000 and 2,500g
- Being placed in an incubator
Exclusion Criteria:
- Abdominal wall defect or myelomeningocele
- Major congenital anomalies
- Blistering skin disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: Incubator-no plastic bag
Placement into an incubator without a plastic bag
|
Infant will be placed in the incubator, wrapped in a blanket, with a cloth hat, according to standard protocol.
|
Active Comparator: Incubator-torso bag
Placement into a plastic bag inside incubator
|
While being placed into an incubator, infant will be placed into a plastic bag to his/her axillae and the bag will be folded and taped to itself to prevent it from covering the infant's nose or mouth.
The infant will be wrapped in a blanket over the plastic bag and will receive a cloth hat.
He/she will remain in the bag for one hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Axillary temperature 36.5-37.5 degrees Celsius
Time Frame: 1-72 hours
|
Temperature taken per axilla for 1 minute
|
1-72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Seizure
Time Frame: Up to 4 weeks
|
Seizure activity diagnosed by medical doctor or nurse.
No electroencephalogram will be done.
|
Up to 4 weeks
|
Pneumothorax
Time Frame: Up to 4 weeks
|
Either chest radiograph documentation or clinical deterioration consistent with air leak
|
Up to 4 weeks
|
Sepsis
Time Frame: Up to 4 weeks
|
Culture proven or culture negative clinically treated course consistent with sepsis
|
Up to 4 weeks
|
Death
Time Frame: Up to 4 weeks
|
Cardiorespiratory failure
|
Up to 4 weeks
|
Hyperthermia
Time Frame: Up to 4 weeks
|
Axillary temperature > 38 degrees Celsius per temperature taken per axilla for one minute
|
Up to 4 weeks
|
Blood glucose
Time Frame: Up to 4 weeks
|
Measure of blood glucose per laboratory value taken per heel stick
|
Up to 4 weeks
|
Weight gain
Time Frame: Up to 4 weeks
|
Infant will be weighed daily and rates of weight gain will be calculated
|
Up to 4 weeks
|
Major brain injury
Time Frame: Up to 4 weeks
|
Intracranial hemorrhage grade 3-4 or periventricular leukomalacia documented on cranial ultrasound
|
Up to 4 weeks
|
Pulmonary hemorrhage
Time Frame: Up to 4 weeks
|
Blood seen in the endotracheal tube and treated by physician
|
Up to 4 weeks
|
Blood Pressure
Time Frame: Up to 4 weeks
|
Measure of extremity blood pressure per cuff taken during nursery stay
|
Up to 4 weeks
|
Respiratory Distress Syndrome (RDS) Respiratory Distress Syndrome (RDS)
Time Frame: Up to 4 weeks
|
Documentation of increased work of breathing, retractions, and a need for oxygen, intubation, or surfactant
|
Up to 4 weeks
|
Bronchopulmonary dysplasia (BPD)
Time Frame: 28 days after birth
|
Oxygen requirement at 28 days after birth
|
28 days after birth
|
Necrotizing enterocolitis or intestinal perforation
Time Frame: Up to 4 weeks
|
Documentation of pneumatosis or intestinal perforation on x-ray or treatment course for clinical necrotizing enterocoliities per Bell's Classification stage greater than 1.
|
Up to 4 weeks
|
Length of time in Incubator
Time Frame: Up to 4 weeks
|
Documentation of length of time spent in incubator and number of times placed in incubator
|
Up to 4 weeks
|
Temperature and humidity
Time Frame: 1 hour
|
A recording of the air temperature and humidity within the incubator will be obtained with each axillary temperature measurement
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2012
Primary Completion (Anticipated)
October 1, 2018
Study Completion (Anticipated)
October 1, 2019
Study Registration Dates
First Submitted
May 21, 2012
First Submitted That Met QC Criteria
May 21, 2012
First Posted (Estimate)
May 23, 2012
Study Record Updates
Last Update Posted (Actual)
February 20, 2019
Last Update Submitted That Met QC Criteria
February 18, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UAB Neo 008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypothermia
-
RECIO PÉREZ, JESÚSUniversity of AlcalaCompletedHypothermia; Anesthesia | Hypothermia Following Anesthesia | Hypothermia Following Anesthesia, Sequela | Hypothermia Due to AnestheticSpain
-
The University of Texas Health Science Center,...RecruitingHypothermia; Anesthesia | Hypothermia, Newborn | Hypothermia, SequelaUnited States
-
Michael Garron HospitalCompletedHypothermia | Body Temperature Changes | Hypothermia Following Anesthesia | Hypothermia, Accidental | Hypothermia Due to AnestheticCanada
-
Centre Leon BerardCompletedHypothermia | Hypothermia; Anesthesia | Hypothermia, AccidentalFrance
-
Marmara UniversityCompletedHypothermia; Anesthesia | Hypothermia Following AnesthesiaTurkey
-
Marmara UniversityCompletedHypothermia; Anesthesia | Hypothermia Following AnesthesiaTurkey
-
Ciusss de L'Est de l'Île de MontréalCompletedHypothermia Following Anesthesia | Hypothermia, AccidentalCanada
-
Ankara Diskapi Training and Research HospitalCompletedPreventing Hypothermia | Perioperative HypothermiaTurkey
-
Universitat Internacional de CatalunyaRecruitingHypothermia | Hypothermia; Anesthesia | Hypothermia, AccidentalSpain
-
Universitair Ziekenhuis BrusselCompletedChildren | Hypothermia; Anesthesia | Hypothermia Following AnesthesiaBelgium
Clinical Trials on Incubator-no plastic bag
-
University of Alabama at BirminghamChildren's Health System, AlabamaCompletedHypothermia | NewbornZambia
-
University of Alabama at BirminghamCompletedHypothermia, NewbornZambia
-
University of Alabama at BirminghamChildren's Health System, AlabamaActive, not recruitingHypothermia | Immature NewbornZambia
-
University of Alabama at BirminghamChildren's of AlabamaCompleted
-
University of Alabama at BirminghamChildren's Health System, AlabamaWithdrawn
-
Universidad Nacional de ColombiaCompleted
-
University Health Network, TorontoCompleted
-
Vanderbilt University Medical CenterCompletedEndotracheal Intubation | Respiratory Failure | Respiratory Failure With HypoxiaUnited States
-
Assiut UniversityUnknownPSGN - Post-Streptococcal Glomerulonephritis
-
Eisai Co., Ltd.Completed